Fortress Biotech (FBIO) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 17, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and annual report before voting.

Voting matters and shareholder proposals

• Election of seven directors is on the agenda, with all nominees recommended by the board.

• Ratification of KPMG LLP as the independent registered public accounting firm for fiscal year ending December 31, 2026.

• Proxy may vote on other business that arises during the meeting or any adjournment.

Board of directors and corporate governance

• Board nominees include Lindsay A. Rosenwald, Michael S. Weiss, Jimmie Harvey Jr., Malcolm Hoenlein, Dov Klein, J. Jay Lobell, and Kevin L. Lorenz.